Correction to: Lonafarnib: First Approval

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1179-1950
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Correction to: Lonafarnib: First Approval ; volume:81 ; number:5 ; day:23 ; month:3 ; year:2021 ; pages:619 ; date:4.2021
Drugs ; 81, Heft 5 (23.3.2021), 619, 4.2021

Urheber
Dhillon, Sohita
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s40265-021-01500-6
URN
urn:nbn:de:101:1-2021060509202289056223
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:45 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Dhillon, Sohita
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Correction to: Pexidartinib: First Approval

Correction to: Pexidartinib: First Approval

Correction to: Lenacapavir: First Approval

Correction to: Lenacapavir: First Approval

Correction to: Nedosiran: First Approval

Correction to: Nedosiran: First Approval

Correction to: Triheptanoin: First Approval

Correction to: Triheptanoin: First Approval

Correction to: Ritlecitinib: First Approval

Correction to: Ritlecitinib: First Approval

Correction to: Zavegepant: First Approval

Correction to: Zavegepant: First Approval

Correction to: Filgotinib: First Approval

Correction to: Filgotinib: First Approval

Correction to: Sotorasib: First Approval

Correction to: Sotorasib: First Approval

Correction to: Inclisiran: First Approval

Correction to: Inclisiran: First Approval

Correction to: Tralokinumab: First Approval

Correction to: Tralokinumab: First Approval

Correction to: Spesolimab: First Approval

Correction to: Spesolimab: First Approval

Correction to: Ubrogepant: First Approval

Correction to: Ubrogepant: First Approval

Verbundene Objekte